1
|
Levenson M, He W, Chen L, Dharmarajan S, Izem R, Meng Z, Pang H, Rockhold F. Statistical consideration for fit-for-use real-world data to support regulatory decision making in drug development. Stat Biopharm Res 2022. [DOI: 10.1080/19466315.2022.2120533] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/14/2022]
Affiliation(s)
| | - Weili He
- Global Medical Affairs Statistics, Data and Statistical Sciences, AbbVie, North Chicago, IL
| | - Li Chen
- Global Medical Affairs Statistics, Data and Statistical Sciences, AbbVie, North Chicago, IL
| | | | - Rima Izem
- Novartis Institutes for BioMedical Research Basel, Basel, Basel-Stadt, CH
| | | | | | - Frank Rockhold
- Department of Biostatistics & Bioinformatics, Duke University, Durham, NC
- Duke Clinical Research Institute, Duke University, Durham, NC
| |
Collapse
|
2
|
Clinical Trials with External Control: Beyond Propensity Score Matching. STATISTICS IN BIOSCIENCES 2022. [DOI: 10.1007/s12561-022-09341-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|